Cargando…
Relationship Between β‐Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
BACKGROUND: The evidence supporting the use of β‐blockers in patients with acute coronary syndrome after successful percutaneous coronary intervention has been inconsistent and scarce. METHODS AND RESULTS: Between March 1, 2009, and December 30, 2014, a total of 3180 eligible patients with acute cor...
Autores principales: | Li, Chenze, Sun, Yang, Shen, Xiaoqing, Yu, Ting, Li, Qing, Ruan, Guoran, Zhang, Lina, Huang, Qiang, Zhuang, Hang, Huang, Jingqiu, Ni, Li, Wang, Luyun, Jiang, Jiangang, Wang, Yan, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210364/ https://www.ncbi.nlm.nih.gov/pubmed/27852588 http://dx.doi.org/10.1161/JAHA.116.004190 |
Ejemplares similares
-
Associations of common variants at ALDH2 gene and the risk of stroke in patients with coronary artery diseases undergoing percutaneous coronary intervention
por: You, Ling, et al.
Publicado: (2018) -
Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Li, Husheng, et al.
Publicado: (2023) -
ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure
por: Huang, Jin, et al.
Publicado: (2018) -
Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis
por: Guo, Wenqin, et al.
Publicado: (2020) -
Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention
por: Tian, Min, et al.
Publicado: (2019)